YUMANITY THERAPEUTICS INC's ticker is YMTX and the CUSIP is 98872L102. A total of 30 filers reported holding YUMANITY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | -47.2% | 10,672 | -55.1% | 0.00% | 0.0% |
| Q1 2022 | $36,000 | -48.6% | 23,789 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $70,000 | -71.5% | 23,789 | 0.0% | 0.00% | -71.4% |
| Q3 2021 | $246,000 | +45.6% | 23,789 | -92.2% | 0.01% | +40.0% |
| Q2 2021 | $169,000 | -35.5% | 304,475 | +2000.1% | 0.01% | -50.0% |
| Q1 2021 | $262,000 | +6.5% | 14,498 | 0.0% | 0.01% | +11.1% |
| Q4 2020 | $246,000 | – | 14,498 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 108,847 | $1,850,000 | 1.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,434 | $2,217,000 | 0.20% |
| HARBOURVEST PARTNERS LLC | 22,030 | $375,000 | 0.15% |
| Redmile Group, LLC | 611,003 | $10,387,000 | 0.13% |
| Ikarian Capital, LLC | 132,514 | $2,253,000 | 0.10% |
| Artal Group S.A. | 217,391 | $3,696,000 | 0.08% |
| Maven Securities LTD | 43,478 | $739,000 | 0.07% |
| Bain Capital Public Equity Management II, LLC | 31,331 | $533,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 14,498 | $246,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11,000 | $187,000 | 0.00% |